Leucocyte common antigen (CD45) and CD5 positivity in an "undifferentiated" carcinoma: A potential diagnostic pitfall

Journal of Clinical Pathology

Volumn 60, Issue 8, 2007, Pages 936-938

  Ngo, Nyethane ^a   Patel, Kaushik ^b   Isaacson, Peter G ^c   Naresh, Kikkeri N ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b KINGSTON HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD45RA ANTIGEN; CD45RB ANTIGEN; CD45RO ANTIGEN; CYTOKERATIN; ISOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; AUTOPSY; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; GASTROINTESTINAL ENDOSCOPY; HEMATOPOIETIC CELL; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; UNDIFFERENTIATED CARCINOMA;

ANTIGENS, CD45; ANTIGENS, CD5; CELL DIFFERENTIATION; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PHARYNGEAL NEOPLASMS;

EID: 34547801304     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.044750     Document Type: Article

References (12)

1. Dawes R, Petrova S, Liu Z, et al. Combinations of CD45 isoforms are crucial for immune function and disease. J Immunol 2006;176:3417-25.
2. Furukawa T, Itoh M, Krueger NX, et al. Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine-phosphorylated CD3 zeta chain. Proc Natl Acad Sci USA 1994;91:10928-32.
3. Kurtin PJ, Pinkus GS. Leukocyte common antigen - a diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization. Hum Pathol 1985;16:353-65.
4. Michels S, Swanson PE, Frizzera G, et al. Immunostaining for leukocyte common antigen using an amplified avidin-biotin-peroxidase complex method and paraffin sections. A study of 735 hematopoietic and nonhematopoietic human neoplasms. Arch Pathol Lab Med 1987;111:1035-9.
5. McDonnell JM, Beschorner WE, Kuhajda FP, et al. Common leukocyte antigen staining of a primitive sarcoma. Cancer 1987;59:1438-41.
6. Nandedkar MA, Palazzo J, Abbondanzo SL, et al. CD45 (leukocyte common antigen) immunoreadivity in metastatic undifferentiated and neuroendocrine carcinoma: a potential diagnostic pitfall. Mod Pathol 1998;11:1204-10.
7. Pomplun S, Wotherspoon AC, Shah G, et al. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Histopathology 2002;40:152-8.
8. Tateyama H, Eimoto T, Tada T, et al. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma. Am J Clin Pathol 1999;111:235-40.
9. Kornstein MJ, Rosai J. CD5 labelling of thymic carcinomas and other nonlymphoid neoplasms. Am J Clin Pathol 1998;109:722-6.5.
10. Tabibzadeh SS, Kong QF, Kapur S. Passive acquisition of leukocyte proteins is associated with changes in phosphorylation of cellular proteins and cell-cell adhesion properties. Am J Pathol 1994;145:930-40.
11. Waldburger JM, Rossi S, Hollander GA, et al. Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells. Blood 2003;101:3550-9.
12. Lasota J, Hyjek E, Koo CH, et al. Cytokeratin-positive large-cell lymphomas of B-cell lineage. A study of five phenotypically unusual cases verified by polymerase chain reaction. Am J Surg Pathol 1996;20:346-54.